Intrexon | 판매 및 관리 비용





판매 및 관리 비용 변화 날짜
Agenus USD 23.6M 448K 2025-09
Alaunos Therapeutics USD 585K 260K 2025-09
Amgen USD 1.94B 237M 2025-12
Anika Therapeutics USD 12.91M 17.8M 2025-03
Arrowhead Research USD 46.02M 8.84M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Heron Therapeutics USD 23.34M 4.18M 2024-09
Incyte USD 390.41M 61.33M 2025-12
Intrexon USD 10.31M 41K 2024-06
Karyopharm Therapeutics USD 27.19M 442K 2024-12
Ligand Pharmaceuticals USD 28.45M 8.27M 2025-09
MacroGenics USD 9.9M 600K 2025-09
MannKind USD 29.09M 2.53M 2025-09
Merck USD 2.85B 215M 2025-12
Novartis USD 3.31B 134M 2025-09
Rigel Pharmaceuticals USD 27.04M 1M 2024-09
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Thermo Fisher Scientific USD 1.98B 182M 2025-12
Veracyte USD 51.73M 5.91M 2025-09
Xencor USD 87.78M 72.66M 2025-09


Intrexon 판매 및 관리 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.